Blockade of A2A adenosine receptors leads to c-fos inhibition in a rat model of brain ischemia

Pharmacological Research

Volumn 45, Issue 2, 2002, Pages 125-128

  Petroni, Anna ^a   Papini, N ^a   Blasevich, M ^a   Galli, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

A2A receptors; Adenosine; Brain ischemia; c fos

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RIGHT HEMISPHERE;

EID: 0036443823     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0918     Document Type: Article

References (18)

1. Galli C, Petroni A. Modulation of arachidonic acid activation in the ischemic brain. In: Lipid Mediators in Ischemic Brain Damage and Experimental Epilepsy. New Trends in Lipid Mediators Research vol. 4, Bazan NG, ed. Basel: Karger, 1990: 18-35.
2. Bazan NG. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 1970; 218: 1-10.
3. Bazan NG. Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock. Adv Exp Med Biol 1976; 72: 317-35.
4. Siesjö BK. A new perspective on ischemic brain damage? Prog Brain Res 1993; 96: 1-9.
5. Hughes P, Dragunow M. Induction of immediate early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 1995; 47: 133-78.
6. Akins PT, Liu PK, Hsu CY. Immediate early gene expression in response to cerebral ischemia. Stroke 1996; 27: 1682-7.
7. Fredholm BB, Abbracchio MP, Bumstook G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994 IV; 46: 143-56.
8. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 1992; 13: 439-45.
9. O'Regan MH, Simpson RE, Perkins LM, Phillis JW. The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci Lett 1992; 138: 169-72.
10. Von Lubitz DKJE. Adenosine and cerebral ischemia: Therapeutic future or death of a brave concept? Eur J Pharmacol 1999; 371: 85-102.
11. 2A receptors: An overview. Brain Res Rev 1999; 31: 65-82.
12. 2A adenosine receptor antagonist. Drug Dev Res 1997; 42: 53-70.
13. 2A receptors by SCH58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport 1998; 9: 3955-9.
14. Zea Longa E, Weinstein PR. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
15. Basheer R, Sherin JE, Saper CB, Morgan JI, McCarley RW, Shiromani PJ. Effects of sleep on wake-induced c-fos expression. J Neurosci 1997; 17: 9746-50.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
17. Nowak TS Jr, Osborne OC, Suga S. Stress protein and proto-oncogene expression as indicators of neuronal pathophysiology after ischemia. In: Progress in Brain Research, vol. 96. Kogure K, Hossmann KA, Siesjo BK, eds. Amsterdam: Elsevier, 1993: 195-208.
18. Simpson RE, O'Regan MH, Perkins LM, Phillis JW. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: Effects of adenosine receptor agonists and antagonists. J Neurochem 1992; 58: 1683-90.